Taxane-induced morphea in a patient with CREST syndrome
The taxanes, docetaxel and paclitaxel, are microtubule stabilizing chemotherapeutic agents that have demonstrated antineoplastic effects in a variety of solid tumors. They have been linked to the development of localized cutaneous sclerosis in some patients. We present a case of docetaxel-induced cutaneous sclerosis of the lower extremities in a patient with pre-existing CREST syndrome. We propose that patients with a history of limited or diffuse systemic sclerosis should be given taxane chemotherapy with caution, as these patients may have an immunological predisposition for the development of drug-induced morphea.
CREST syndrome; scleroderma; morphea; docetaxel; taxane
Submitted: 2010-06-29 21:32:13
Published: 2010-07-20 08:42:49
Search for citations in Google Scholar
Related articles: Google Scholar